{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:06:34Z","timestamp":1782770794622,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.7759\/cureus.70337","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:29:39Z","timestamp":1727454579000},"source":"Crossref","is-referenced-by-count":4,"title":["The Impact of Diet on Parkinson's Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Luqman","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Faisal Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"ibad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey E","year":"2018","unstructured":"Dorsey E. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17:939-53. 10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira AH","year":"2017","unstructured":"Schapira AH, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017, 18:435-50. 10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia LV","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015, 386:896-912. 10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature","volume":"32","author":"Schneider SA","year":"2017","unstructured":"Schneider SA, Alcalay RN. Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord. 2017, 32:1504-23. 10.1002\/mds.27193","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27186","article-title":"Neuropathology of autonomic dysfunction in synucleinopathies","volume":"33","author":"Coon EA","year":"2018","unstructured":"Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018, 33:349-58. 10.1002\/mds.27186","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson's disease: targets for potential treatments","volume":"6","author":"Maiti P","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL. Current understanding of the molecular mechanisms in Parkinson's disease: targets for potential treatments. Transl Neurodegener. 2017, 6:28. 10.1186\/s40035-017-0099-z","journal-title":"Transl Neurodegener"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-014-8294-x","article-title":"Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease","volume":"16","author":"Gaki GS","year":"2014","unstructured":"Gaki GS, Papavassiliou AG. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromolecular Med. 2014, 16:217-30. 10.1007\/s12017-014-8294-x","journal-title":"Neuromolecular Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061995","article-title":"Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets","volume":"9","author":"Scioli MG","year":"2020","unstructured":"Scioli MG, Storti G, D'Amico F, et al.. Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets. J Clin Med. 2020, 9:1995. 10.3390\/jcm9061995","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio A","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001, 50:56-63. 10.1002\/ana.1052","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555","article-title":"Gut microbiota: a novel therapeutic target for Parkinson's disease","volume":"13","author":"Zhu M","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, et al.. Gut microbiota: a novel therapeutic target for Parkinson's disease. Front Immunol. 2022, 13:937555. 10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1890330","article-title":"The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance","volume":"53","author":"Menozzi E","year":"2021","unstructured":"Menozzi E, Macnaughtan J, Schapira AH. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med. 2021, 53:611-25. 10.1080\/07853890.2021.1890330","journal-title":"Ann Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms","volume":"27","author":"Felice VD","year":"2016","unstructured":"Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW, O'Mahony SM. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord. 2016, 27:1-8. 10.1016\/j.parkreldis.2016.03.012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1235","article-title":"Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials","volume":"1","author":"Unger JM","year":"2018","unstructured":"Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL. Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials. JAMA Netw Open. 2018, 1:e181235. 10.1001\/jamanetworkopen.2018.1235","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-200202000-00002","article-title":"Dietary pattern analysis: a new direction in nutritional epidemiology","volume":"13","author":"Hu FB","year":"2002","unstructured":"Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002, 13:3-9. 10.1097\/00041433-200202000-00002","journal-title":"Curr Opin Lipidol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1344","article-title":"Adherence to Mediterranean diet and health status: meta-analysis","volume":"337","author":"Sofi F","year":"2008","unstructured":"Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008, 337:a1344. 10.1136\/bmj.a1344","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980007001279","article-title":"Whole-grain intake as a marker of healthy body weight and adiposity","volume":"11","author":"Harland JI","year":"2008","unstructured":"Harland JI, Garton LE. Whole-grain intake as a marker of healthy body weight and adiposity. Public Health Nutr. 2008, 11:554-63. 10.1017\/S1368980007001279","journal-title":"Public Health Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study","volume":"64","author":"de Lau LM","year":"2005","unstructured":"de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology. 2005, 64:2040-5. 10.1212\/01.WNL.0000166038.67153.9F","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa J","year":"2010","unstructured":"Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis. 2010, 20:S221-38. 10.3233\/JAD-2010-091525","journal-title":"J Alzheimers Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004057","article-title":"Intake of dairy foods and risk of Parkinson disease","volume":"89","author":"Hughes KC","year":"2017","unstructured":"Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A. Intake of dairy foods and risk of Parkinson disease. Neurology. 2017, 89:46-52. 10.1212\/WNL.0000000000004057","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmab060","article-title":"Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: a systematic review","volume":"12","author":"Boelens Keun JT","year":"2021","unstructured":"Boelens Keun JT, Arnoldussen IA, Vriend C, van de Rest O. Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: a systematic review. Adv Nutr. 2021, 12:2265-87. 10.1093\/advances\/nmab060","journal-title":"Adv Nutr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1007654","article-title":"Efficacy and safety of probiotics in Parkinson's constipation: a systematic review and meta-analysis","volume":"13","author":"Xie L","year":"2022","unstructured":"Xie L, Chen D, Zhu X, Cheng C. Efficacy and safety of probiotics in Parkinson's constipation: a systematic review and meta-analysis. Front Pharmacol. 2022, 13:1007654. 10.3389\/fphar.2022.1007654","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105816","article-title":"Diet quality and Parkinson's disease: potential strategies for non-motor symptom management","volume":"115","author":"Kwon D","year":"2023","unstructured":"Kwon D, Folle AD, Del Rosario I, et al.. Diet quality and Parkinson's disease: potential strategies for non-motor symptom management. Parkinsonism Relat Disord. 2023, 115:105816. 10.1016\/j.parkreldis.2023.105816","journal-title":"Parkinsonism Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.10.013","article-title":"Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment","volume":"50","author":"Salim S","year":"2023","unstructured":"Salim S, Ahmad F, Banu A, Mohammad F. Gut microbiome and Parkinson's disease: perspective on pathogenesis and treatment. J Adv Res. 2023, 50:83-105. 10.1016\/j.jare.2022.10.013","journal-title":"J Adv Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1273874","article-title":"Correlation between dietary factors and Parkinson's disease revealed by the analysis of Mendelian randomization","volume":"11","author":"Zeng S","year":"2024","unstructured":"Zeng S, Yusufujiang A, Zhang C, Yang C, Li H. Correlation between dietary factors and Parkinson's disease revealed by the analysis of Mendelian randomization. Front Nutr. 2024, 11:1273874. 10.3389\/fnut.2024.1273874","journal-title":"Front Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2023.2233727","article-title":"A comprehensive examination of the evidence for whole of diet patterns in Parkinson's disease: a scoping review","volume":"27","author":"Rees J","year":"2024","unstructured":"Rees J, Ryan J, Laws M, Devine A. A comprehensive examination of the evidence for whole of diet patterns in Parkinson's disease: a scoping review. Nutr Neurosci. 2024, 27:547-65. 10.1080\/1028415X.2023.2233727","journal-title":"Nutr Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02635-4","article-title":"The heterogeneity of Parkinson's disease","volume":"130","author":"W\u00fcllner U","year":"2023","unstructured":"W\u00fcllner U, Borghammer P, Choe CU, et al.. The heterogeneity of Parkinson's disease. J Neural Transm (Vienna). 2023, 130:827-38. 10.1007\/s00702-023-02635-4","journal-title":"J Neural Transm (Vienna)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2022.10.003","article-title":"Integrating nutriepigenomics in Parkinson's disease management: new promising strategy in the omics era","volume":"13","author":"Razali K","year":"2022","unstructured":"Razali K, Algantri K, Loh SP, Cheng SH, Mohamed W. Integrating nutriepigenomics in Parkinson's disease management: new promising strategy in the omics era. IBRO Neurosci Rep. 2022, 13:364-72. 10.1016\/j.ibneur.2022.10.003","journal-title":"IBRO Neurosci Rep"},{"key":"ref28","article-title":"J Parkinsons Dis","volume":"3","author":"Dias V","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM. J Parkinsons Dis. The role of oxidative stress in Parkinson\u2019s disease. 2013, 3:461-91.","journal-title":"The role of oxidative stress in Parkinson\u2019s disease"},{"key":"ref29","article-title":"Exploring the connection between the gut microbiome and Parkinson's disease symptom progression and pathology: implications for supplementary treatment options","volume":"12","author":"Chan DG","year":"2022","unstructured":"Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR. Exploring the connection between the gut microbiome and Parkinson's disease symptom progression and pathology: implications for supplementary treatment options. J Parkinsons Dis. 2022, 12:2339-52.","journal-title":"J Parkinsons Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-a call to action","volume":"75","author":"Dorsey ER","year":"2018","unstructured":"Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018, 75:9-10. 10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"key":"ref31","article-title":"Parkinson's disease drug therapies in the clinical trial pipeline: 2022 update","volume":"12","author":"McFarthing K","year":"2022","unstructured":"McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, Stott SR. Parkinson's disease drug therapies in the clinical trial pipeline: 2022 update. J Parkinsons Dis. 2022, 12:1073-82.","journal-title":"J Parkinsons Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref33","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong QN","year":"2018","unstructured":"Hong QN, F\u00e0bregues S, Bartlett G, et al.. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018, 34:285-91.","journal-title":"Educ Inf"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.5.1486","article-title":"Prospective study of dietary pattern and risk of Parkinson disease","volume":"86","author":"Gao X","year":"2007","unstructured":"Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007, 86:1486-94. 10.1093\/ajcn\/86.5.1486","journal-title":"Am J Clin Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24918","article-title":"The association between Mediterranean diet adherence and Parkinson\u2019s disease","volume":"27","author":"Alcalay RN","year":"2012","unstructured":"Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson\u2019s disease. Mov Disord. 2012, 27:771-4. 10.1002\/mds.24918","journal-title":"Mov Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6405278","article-title":"Role of diet and nutritional supplements in Parkinson\u2019s disease progression","volume":"2017","author":"Mischley LK","year":"2017","unstructured":"Mischley LK, Lau RC, Bennett RD. Role of diet and nutritional supplements in Parkinson\u2019s disease progression. Oxid Med Cell Longev. 2017, 2017:10.1155\/2017\/6405278","journal-title":"Oxid Med Cell Longev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial","volume":"33","author":"Phillips MC","year":"2018","unstructured":"Phillips MC, Murtagh DK, Gilbertson LJ, Asztely FJ, Lynch CD. Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial. Mov Disord. 2018, 33:1306-14. 10.1002\/mds.27390","journal-title":"Mov Disord"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102366","article-title":"The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: a randomized clinical controlled trial","volume":"50","author":"Paknahad Z","year":"2020","unstructured":"Paknahad Z, Sheklabadi E, Derakhshan Y, Bagherniya M, Chitsaz A. The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: a randomized clinical controlled trial. Complement Ther Med. 2020, 50:102366. 10.1016\/j.ctim.2020.102366","journal-title":"Complement Ther Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.794640","article-title":"Mediterranean diet adherence in people with Parkinson's disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study","volume":"12","author":"Rusch C","year":"2021","unstructured":"Rusch C, Beke M, Tucciarone L, et al.. Mediterranean diet adherence in people with Parkinson's disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study. Front Neurol. 2021, 12:794640. 10.3389\/fneur.2021.794640","journal-title":"Front Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1278128","article-title":"Association between dietary intake and risk of Parkinson's disease: cross-sectional analysis of survey data from NHANES 2007-2016","volume":"10","author":"Liu L","year":"2023","unstructured":"Liu L, Shen Q, Bao Y, et al.. Association between dietary intake and risk of Parkinson's disease: cross-sectional analysis of survey data from NHANES 2007-2016. Front Nutr. 2023, 10:1278128. 10.3389\/fnut.2023.1278128","journal-title":"Front Nutr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson's disease","volume":"10","author":"Kwon D","year":"2024","unstructured":"Kwon D, Zhang K, Paul KC, et al.. Diet and the gut microbiome in patients with Parkinson's disease. NPJ Parkinsons Dis. 2024, 10:89. 10.1038\/s41531-024-00681-7","journal-title":"NPJ Parkinsons Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-07204-x","article-title":"Association between major dietary patterns and Parkinson's disease risk: a case-control study","volume":"45","author":"Shokri-Mashhadi N","year":"2024","unstructured":"Shokri-Mashhadi N, Ghiasvand R, Feizi A, Ebrahimi-Monfared M, Vahid F, Banijamali A. Association between major dietary patterns and Parkinson's disease risk: a case-control study. Neurol Sci. 2024, 45:2003-10. 10.1007\/s10072-023-07204-x","journal-title":"Neurol Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/17582024.2024.2352394","article-title":"Impact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a\u00a0longitudinal study","author":"Tidman MM","year":"2024","unstructured":"Tidman MM, White DR, White TA. Impact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a\u00a0longitudinal study. Neurodegener Dis Manag. 2024, 1-14. 10.1080\/17582024.2024.2352394","journal-title":"Neurodegener Dis Manag"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27489","article-title":"Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease","volume":"34","author":"Maraki MI","year":"2019","unstructured":"Maraki MI, Yannakoulia M, Stamelou M, et al.. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease. Mov Disord. 2019, 34:48-57. 10.1002\/mds.27489","journal-title":"Mov Disord"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-024-00539-7","article-title":"Modulation of gut microbiota through dietary intervention in neuroinflammation and Alzheimer's and Parkinson's diseases","volume":"13","author":"Ayten \u015e","year":"2024","unstructured":"Ayten \u015e, Bilici S. Modulation of gut microbiota through dietary intervention in neuroinflammation and Alzheimer's and Parkinson's diseases. Curr Nutr Rep. 2024, 13:82-96. 10.1007\/s13668-024-00539-7","journal-title":"Curr Nutr Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010042","article-title":"Mediterranean diet and Parkinson's disease","volume":"24","author":"Bisaglia M","year":"2022","unstructured":"Bisaglia M. Mediterranean diet and Parkinson's disease. Int J Mol Sci. 2022, 24:42. 10.3390\/ijms24010042","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-024-01459-4","article-title":"Iron deposition in Parkinson's disease: a mini-review","volume":"44","author":"Zeng W","year":"2024","unstructured":"Zeng W, Cai J, Zhang L, Peng Q. Iron deposition in Parkinson's disease: a mini-review. Cell Mol Neurobiol. 2024, 44:26. 10.1007\/s10571-024-01459-4","journal-title":"Cell Mol Neurobiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320722","article-title":"A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease","volume":"32","author":"Fahn S","year":"1992","unstructured":"Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann Neurol. 1992, 32:S128-32. 10.1002\/ana.410320722","journal-title":"Ann Neurol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans F","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, et al.. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord. 2015, 30:350-8. 10.1002\/mds.26069","journal-title":"Mov Disord"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji OR","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, et al.. Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019, 38:1031-5. 10.1016\/j.clnu.2018.05.018","journal-title":"Clin Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292057-the-impact-of-diet-on-parkinsons-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:29:41Z","timestamp":1727454581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292057-the-impact-of-diet-on-parkinsons-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.70337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}